A Novel Histology-directed Strategy for MALDI-MS Tissue Profiling That Improves Throughput and Cellular Specificity in Human Breast Cancer*

  1. Dale S. Cornett§,
  2. James A. Mobley§,
  3. Eduardo C. Dias,
  4. Malin Andersson§,
  5. Carlos L. Arteaga**‡‡,
  6. Melinda E. Sanders§§‡‡ and
  7. Richard M. Caprioli§‡‡¶¶
  1. From the Departments of Biochemistry, §§Pathology, Medicine, and **Cancer Biology, §Vanderbilt Mass Spectrometry Research Center, ‡‡Breast Cancer Research Program, Vanderbilt-Ingram Comprehensive Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
  1. ¶¶To whom correspondence should be addressed: Mass Spectrometry Research Center, 9160 MRB III, Vanderbilt University, Nashville, TN 37232-8575. Tel.: 1-615-343-9207; Fax: 1-615-343-8372; E-mail: r.caprioli{at}vanderbilt.edu

Abstract

We describe a novel tissue profiling strategy that improves the cellular specificity and analysis throughput of protein profiles obtained by direct MALDI analysis. The new approach integrates the cellular specificity of histology, the accuracy and reproducibility of robotic liquid dispensing, and the speed and objectivity of automated spectra acquisition. Traditional methodologies for preparing and analyzing tissue samples rely heavily on manual procedures, which for various reasons discussed, restrict cellular specificity and sample throughput. Here, a robotic spotter deposits micron-sized droplets of matrix precisely onto foci of normal mammary epithelium, ductal carcinoma in situ, invasive mammary cancer, and peritumoral stroma selected by a pathologist from high resolution histological images of sectioned human breast cancer samples. The location of each matrix spot was then determined and uploaded into the instrument to facilitate automated profile acquisition by MALDI-TOF. In the example shown, the different lesions were clearly differentiated using mass profiling. Further, the workflow permits a visual projection of any information produced from the profile analyses directly on the histological image for a unique combination of proteomic and histological assessment of sample regions. The higher performance characteristics offered by the new workflow promises to be a significant advancement toward the next generation of tissue profiling studies.

Footnotes

  • Published, July 18, 2006, MCP Papers in Press, DOI 10.1074/mcp.M600119-MCP200

  • 1 The abbreviations used are: LCM, laser capture microdissection; IMC, invasive mammary carcinoma; DCIS, ductal carcinoma in situ; H&E, hematoxylin and eosin; NTE, non-transformed epithelium; MDS, multidimensional scaling

  • * This work was supported in part by NIH/NCI/NIDA Grants IR33-CA86243 and R01 CA80195, Breast Cancer Specialized Program of Research Excellence (SPORE) Grant P50 CA98131, Vanderbilt-Ingram Comprehensive Cancer Center Support Grant P30 CA68485, and Komen Foundation Award BTR0504154.

    The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Supported by an Avon Foundation-American Association for Cancer Research International Scholar Award.

    • Received April 5, 2006.
    • Accepted July 3, 2006.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement